Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines

Posted On: 2023-10-16 10:41:24 (Time Zone: IST)

Building upon its sizeable presence in the oncology space in the Association of Southeast Asian Nations (ASEAN) region, Venus Remedies Ltd, a well-known provider of affordable cancer drugs worldwide, has received marketing approval from the Philippines, the second largest ASEAN market, for six key chemotherapy drugs.

Venus Remedies has secured marketing authorisation for bortezomih cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines, thus making it a significant market for the company from the ASEAN region.

With this, Venus Remedies has secured 525 marketing approvals for its oncology products across 76 Countries.

The $420Lbillion pharmaceutical market of the Philippines, a growing market for cancer drugs where Venus Remedies has so far secured marketing approval for 52 products across various segments, presents immense opportunities for the company to expand its operations in the Asia-Pacific region in general and Southeast Asia in particular through its elaborate range of drugs.

Stating that this achievement marks a significant step towards achieving the company's goal of emerging as the top oncology medicine supplier from India in Southeast Asia, Saransh Chaudhary, CEO, Venus Medicine Research Centre said, "While oncology drugs account for 157 of our 205 marketing authorisations in the ASEAN region, we are banking on these product registrations from the Philippines to pave the way for faster approval of these drugs in other Southeast Asian countries as well. Consequently, we will further extend our operations to other ASEAN markets, reaffirming our commitment to provide advanced cancer treatment options with improved outcomes for patients."

Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines government for another 45 marketing authorisations, and most of these pending approvals are for oncology products. Pertinently, the market size of cancer drugs in the Philippines was valued at US $252 billion in 2020 and is expected to grow at a CAGR of 8.7% by 2025.

Meanwhile, executing its expansion plans in the ASEAN region, the company's oncology wing has also secured marketing approval from Myanmar for the chemotherapy drug oxaliplatin. Three months after Venus Remedies had got marketing authorisation from Malaysia, one of the largest pharmaceutical markets in Southeast Asia, for another chemotherapy medication, pemetrexed, the company has now secured a product registration for a different dosage of the same drug. Venus Remedies' oncology products are widely used in many big chemotherapy centres in Malaysia. like Onco Life.

Terming these marketing approvals as a testimony to the company's uncompromising quality standards, Venus Remedies Executive Director Akshansh Chaudhary said, "We will continue to maximise our expertise, regulatory might and global partnerships to provide access to advanced cancer therapies which can improve the lives of patients around the globe."

Shares of Venus Remedies Limited was last trading in BSE at Rs. 227.60 as compared to the previous close of Rs. 230.40. The total number of shares traded during the day was 3238 in over 379 trades.

The stock hit an intraday high of Rs. 232.50 and intraday low of 227.00. The net turnover during the day was Rs. 745787.00.

Click here to send ur comments or to

Other Headlines:

Meson Valves India Ltd acquires Milindpra Castings Pvt Ltd

ideaForge Technology Ltd invests in GalaxEye Space Solutions Pvt Ltd

Suryoday Small Finance Bank Ltd sanctions term loan facility of Rs. 10 crore to Star Housing Finance Ltd

Tata Elxsi Ltd reports lower Q1 FY2024-25 net profit of Rs. 184.07 crores

JTL Industries Ltd Q1FY25 consolidated PAT at Rs. 30.70 crores

Vashu Bhagnani Industries Ltd Q1 FY2024-25 consolidated profit at Rs. 5.68 crores

KCP Sugar and Industries Corporation Ltd reports Rs. 54.11 crores consolidated PAT in Q1FY25

Kesoram Industries Ltd Q1FY25 consolidated loss at Rs. 62.02 crores

SG Finserve Ltd Q1 FY2025 net profit slips QoQ to Rs. 19.38 crores

Storage Technologies and Automation Ltd to open new sales branch office at Thane West

UGRO Capital Opens a New Branch Office in Indore to Empower MSMEs

Angel One Reaffirms Robust Data Security and Compliance

Zydus receives tentative approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg

Juniper Green Energy Secures 480 MW in Hybrid PPAs with GUVNL and NTPC

JLR India announced a strong start to FY25

IRCTC & DMRC QR Code Ticketing under 'One India - One Ticket' Initiative

State Bank of India's Senior Unsecured Long Term Bond Issuance

Oriental Rail Infrastructure Ltd secures orders worth Rs. 19.33 crore

Sula Vineyards Limited - Sales Update - Q1 FY25

Ahasolar Technologies Ltd receives order worth Rs. 45 lacs

Westside launches its 229th store in Faridabad

Satin Creditcare Secures 15 Million Euros Debt Funding from OeEB

Pecos Hotels and Pubs Limited recommends final dividend of Rs. 3

TVS Motor Company Launches 2024 TVS Apache RTR 160 - Racing Edition

Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets

Revolt Motors Launches - Industry-First Finance Scheme: '4 Chauke Offer'

OK Play India Limited approves IPO of OK Play Auto Pvt Ltd

Rail Vikas Nigam Limited signs MoU with IMS Consultancy Pvt Ltd

Sky Industries Ltd to participate in Textile Fairs-India 2024

Greaves Finance Ltd partners with ACKO to facilitate seamless EV ownership across India

ITCONS E-Solutions Limited receives contract worth Rs. 41.15 lakhs

GE Power India Ltd receives order from MRPL

Mahan Energen Ltd ceases to be wholly owned subsidiary of Adani Power Ltd

Rail Vikas Nigam Ltd receives LOA from Nagpur Metro

Adani Ports and Special Economic Zone Ltd receives LOI for Berth No.13 at Deendayal Port

Mehai Technology Limited receives order from Sungevity Enterprises Pvt Ltd

Eraaya Lifespaces Ltd Q1FY2025 PAT up at Rs. 95.49 lakhs

Rajnish Wellness Ltd Q1FY25 profit at Rs. 16.70 lakhs

Delta Corp Ltd posts consolidated PAT of Rs. 21.68 crores in Q1 FY2024-25

R S Software India Ltd consolidated Q1 FY25 net profit drops QoQ to Rs. 4.58 crore

Tanishq Opens Expansive Showroom at Omaxe Chowk

Zaggle receives prestigious awards for superior brand and product innovation

Rail Vikas Nigam Limited signs MoU with TATWEER Middle East and Africa LLC

Fusion Micro Finance Ltd is now Fusion Finance Ltd

BLS International Holding Anonim ┼×irketi, Turkey successfully completes acquisition of 100% stake in iDATA

Abans Holdings Limited gets registration of IFSC branch

Advait Infractech Ltd receive LOI from KPI Green Energy Ltd for orders

KIMS HOSPITALS announces acquisition of 200-bed multi-specialty hospital in Vizag

Spectrum Foods Limited converts 1,82,21,671 shares into fully-paid up on receipt of call money

Shilpa Pharma Lifesciences Ltd, Unit 2, Raichur, Karnataka has cleared the ANVISA-Brazil GMP inspection

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020